Disc Medicine Inc
IRON
NASDAQ
Biotechnology
$78.84
USD
-1.17 (-1.46%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.07B
Volume 262.5K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-245.89M
TTM
-69.1%
YoY
Operating Cash Flow
$-197.54M
TTM
-47.2%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 15.1 | 17.4 | 20.7 | 23.6 | 18.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 61.4 | 67.7 | 67.0 | 69.5 | 65.1 |
Operating Income | -61.4 | -67.7 | -67.0 | -69.5 | -65.1 |
EBITDA | -61.3 | -67.6 | -66.9 | -69.4 | -65.0 |
Other Income / Expense | 0.1 | -0.0 | -0.0 | 0.0 | -0.0 |
Total Other Income / Expense | 6.2 | 5.5 | 6.5 | 6.1 | 5.6 |
Income Before Income Taxes | -55.2 | -62.2 | -60.4 | -63.5 | -59.5 |
Income Taxes | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Net Income | -55.2 | -62.3 | -60.5 | -63.5 | -59.5 |
Consolidated Net Income / Loss | -55.2 | -62.3 | -60.5 | -63.5 | -59.5 |
Net Income Attributable to Common Shareholders | -55.2 | -62.3 | -60.5 | -63.5 | -59.5 |
Basic EPS | -$1.58 | -$1.77 | -$1.61 | -$1.65 | -$1.54 |
Diluted EPS | -$1.58 | -$1.77 | -$1.61 | -$1.65 | -$1.54 |
Basic Shares Outstanding | 35.0M | 35.2M | 37.7M | 38.5M | 38.7M |
Diluted Shares Outstanding | 35.0M | 35.2M | 37.7M | 38.5M | 38.7M |